$76.29
Price
$113.1B
Market Cap
39.3
P/E Ratio
19.5
Forward P/E
$1.94
EPS (TTM)
—
Dividend Yield
$1.3B
Cash
$11.1B
Total Debt
1.48B
Shares Out
$72.69
$109.50
52-Week Range
Institutional Ownership of BOSTON SCIENTIFIC CORP
|
Fund / Manager
Click to search
|
Shares | Value | % of Portfolio | Cost Basis | Est. Return |
|---|---|---|---|---|---|
|
Egerton Capital|John Armitage
|
5.4M | $513M | $103.42 | -11.73% | |
|
Lone Pine Capital|Stephen Mandel
|
201.7K | $19M | $97.72 | -21.91% |
Trading Activity for BOSTON SCIENTIFIC CORP
|
Fund / Manager
Click to search
|
Action | Change | Shares After | Value | Price |
|---|---|---|---|---|---|
| 2025-Q4 | |||||
| BUY | +1.4% | 5.4M | $513M | $97.72 | |
| BUY | NEW | 201.7K | $19M | $97.72 | |
| 2025-Q3 | |||||
| BUY | NEW | 5.6M | $547M | $103.86 | |
| BUY | +223.7% | 5.3M | $519M | $103.86 | |
| SELL | -13.3% | 2.6M | $258M | $103.86 | |
| SELL | -1.7% | 88.9K | $9M | $103.86 | |
| SELL | -1.0% | 10.3K | $1M | $103.86 | |
| 2025-Q2 | |||||
| BUY | +28.1% | 3.0M | $327M | $102.43 | |
| BUY | NEW | 1.6M | $176M | $102.43 | |
| SELL | -1.4% | 90.4K | $10M | $102.43 | |
| BUY | +0.9% | 10.4K | $1M | $102.43 | |
| 2025-Q1 | |||||
| BUY | +9.4% | 2.4M | $240M | $101.56 | |
| SELL | -3.3% | 91.7K | $9M | $101.56 | |
| 2024-Q4 | |||||
| BUY | +124.6% | 2.2M | $194M | $88.25 | |
| SELL | -0.5% | 94.8K | $8M | $88.25 | |
| 2024-Q3 | |||||
| BUY | NEW | 967.2K | $81M | $78.25 | |
| SELL | -1.9% | 95.3K | $8M | $78.25 | |
| BUY | +0.4% | 10.3K | $864062 | $78.25 | |
| 2024-Q2 | |||||
| SELL | EXIT | — | — | $74.10 | |
| SELL | -1.9% | 10.3K | $790816 | $74.10 | |
| 2024-Q1 | |||||
| SELL | -23.9% | 1.7M | $118M | $65.75 | |
| BUY | +1.3% | 10.5K | $717022 | $65.75 | |
| 2023-Q4 | |||||
| BUY | +104.2% | 2.3M | $131M | $53.85 | |
| SELL | -0.0% | 97.1K | $6M | $53.85 | |
| BUY | +0.4% | 10.3K | $597466 | $53.85 | |
| 2023-Q3 | |||||
| BUY | NEW | 1.1M | $59M | $52.70 | |
| SELL | -1.8% | 97.1K | $5M | $52.70 | |
| SELL | -4.6% | 10.3K | $543629 | $52.70 | |
| 2023-Q2 | |||||
| SELL | EXIT | — | — | $51.93 | |
| SELL | -6.3% | 98.9K | $5M | $51.93 | |
| BUY | +0.3% | 10.8K | $583956 | $51.93 | |
| 2023-Q1 | |||||
| SELL | -88.1% | 1.1M | $57M | $47.02 | |
| SELL | -6.5% | 105.6K | $5M | $47.02 | |
| 2022-Q4 | |||||
| SELL | -41.0% | 9.5M | $441M | $42.96 | |
| SELL | -2.3% | 112.9K | $5M | $42.96 | |
| 2022-Q3 | |||||
| BUY | +10.3% | 16.2M | $626M | $40.52 | |
| SELL | -4.2% | 115.6K | $4M | $40.52 | |
| BUY | NEW | 10.8K | $417000 | $40.52 | |
| 2022-Q2 | |||||
| BUY | +113.4% | 14.7M | $546M | $40.15 | |
| SELL | EXIT | — | — | $40.15 | |
| 2022-Q1 | |||||
| SELL | -63.8% | 6.9M | $298M | $43.36 | |
| SELL | -4.0% | 120.6K | $5M | $43.36 | |
| BUY | +11.9% | 5.3K | $236000 | $43.36 | |
| 2021-Q4 | |||||
| BUY | +176.2% | 19.0M | $805M | $42.16 | |
| SELL | -3.5% | 125.6K | $5M | $42.16 | |
| 2021-Q3 | |||||
| SELL | -48.4% | 6.9M | $298M | $44.33 | |
| BUY | NEW | 4.8K | $207000 | $44.33 | |
| 2021-Q2 | |||||
| SELL | -25.6% | 13.3M | $569M | $42.37 | |
| SELL | -0.9% | 130.1K | $6M | $42.37 | |
| 2021-Q1 | |||||
| SELL | -40.3% | 17.9M | $692M | $38.10 | |
| SELL | -1.3% | 131.3K | $5M | $38.10 | |
| 2020-Q4 | |||||
| BUY | +59.3% | 30.0M | $1.1B | $35.21 | |
| SELL | EXIT | — | — | $35.21 | |
| SELL | -3.6% | 133.0K | $5M | $35.21 | |
| 2020-Q3 | |||||
| BUY | +2.0% | 18.8M | $719M | $38.60 | |
| SELL | -17.1% | 787.5K | $30M | $38.60 | |
| SELL | -3.6% | 138.0K | $5M | $38.60 | |
| 2020-Q2 | |||||
| SELL | -42.0% | 18.5M | $648M | $36.22 | |
| BUY | +726.1% | 950.0K | $33M | $36.22 | |
| SELL | -13.2% | 143.1K | $5M | $36.22 | |
| 2020-Q1 | |||||
| BUY | +72.1% | 31.8M | $1.0B | $42.22 | |
| SELL | EXIT | — | — | $42.22 | |
| SELL | -5.5% | 164.8K | $5M | $42.22 | |
| BUY | NEW | 115.0K | $4M | $42.22 | |
| SELL | EXIT | — | — | $42.22 | |
| 2019-Q4 | |||||
| BUY | +77.5% | 18.5M | $836M | $41.75 | |
| SELL | -0.1% | 174.4K | $8M | $41.75 | |
| BUY | NEW | 6.8K | $308000 | $41.75 | |
| 2019-Q3 | |||||
| BUY | +13.3% | 10.4M | $424M | $42.46 | |
| SELL | -9.1% | 5.0M | $203M | $42.46 | |
| SELL | -1.1% | 174.6K | $7M | $42.46 | |
| 2019-Q2 | |||||
| BUY | +185.5% | 9.2M | $395M | $38.15 | |
| BUY | +10.0% | 5.5M | $236M | $38.15 | |
| SELL | -0.1% | 176.6K | $8M | $38.15 | |
| 2019-Q1 | |||||
| BUY | NEW | 5.0M | $192M | $38.15 | |
| SELL | -38.1% | 3.2M | $124M | $38.15 | |
| SELL | -10.2% | 176.7K | $7M | $38.15 | |
| 2018-Q4 | |||||
| BUY | +64.8% | 5.2M | $184M | $36.49 | |
| SELL | EXIT | — | — | $36.49 | |
| SELL | -3.6% | 196.8K | $7M | $36.49 | |
| 2018-Q3 | |||||
| BUY | NEW | 3.2M | $122M | $34.33 | |
| SELL | -66.2% | 853.9K | $33M | $34.33 | |
| SELL | -3.6% | 204.3K | $8M | $34.33 | |
| 2018-Q2 | |||||
| SELL | -35.4% | 2.5M | $83M | $30.09 | |
| SELL | -11.1% | 212.0K | $7M | $30.09 | |
| 2018-Q1 | |||||
| SELL | -18.2% | 3.9M | $107M | $27.39 | |
| SELL | -5.9% | 238.4K | $7M | $27.39 | |
Insider Trading for BOSTON SCIENTIFIC CORP
6 Months Insider Sentiment
Buy $0
Sell $19.5M
0
Buys
11
Sells
-19.5M
Net
6
Grants
Largest
$4.1M
Fitzgerald
$3.0M
Fitzgerald
$2.9M
Fitzgerald
| Date |
Insider
Click to search
|
Role
Click to search
|
Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Dec 01, 2025 | Arthur C Butcher | EVP& Grp Pres, MedSurg & APAC | EXERCISE | 1.0K | $17.26 | $17K |
| Dec 01, 2025 | Arthur C Butcher | EVP& Grp Pres, MedSurg & APAC | EXERCISE | 3.2K | $22.71 | $72K |
| Dec 01, 2025 | Arthur C Butcher | EVP& Grp Pres, MedSurg & APAC | EXERCISE | 6.2K | $24.55 | $152K |
| Dec 01, 2025 | Arthur C Butcher | EVP& Grp Pres, MedSurg & APAC | EXERCISE | 7.0K | $27.09 | $188K |
| Dec 01, 2025 | Arthur C Butcher | EVP& Grp Pres, MedSurg & APAC | SELL | 17.3K | $101.55 | $1.8M |
| Nov 28, 2025 | Miriam O'Sullivan | SVP, Chief HR Officer | GRANT | 260 | — | — |
| Nov 14, 2025 | Joseph Michael Fitzgerald | EVP & Group Pres, Cardiology | GRANT | 9.6K | — | — |
| Nov 12, 2025 | Joseph Michael Fitzgerald | EVP & Group Pres, Cardiology | GRANT | 690 | — | — |
| Nov 06, 2025 | Ellen M Zane | Director | SELL | 12.9K | $98.28 | $1.3M |
| Nov 03, 2025 | Joseph Michael Fitzgerald | EVP & Group Pres, Cardiology | SELL | 3.6K | $100.75 | $363K |
| Nov 03, 2025 | Joseph Michael Fitzgerald | EVP & Group Pres, Cardiology | SELL | 29.5K | $99.14 | $2.9M |
| Nov 03, 2025 | Joseph Michael Fitzgerald | EVP & Group Pres, Cardiology | EXERCISE | 50.0K | $26.15 | $1.3M |
| Nov 03, 2025 | Joseph Michael Fitzgerald | EVP & Group Pres, Cardiology | SELL | 16.9K | $99.76 | $1.7M |
| Oct 30, 2025 | Michael F Mahoney | Chairman, President & CEO | GRANT | 150.0K | — | — |
| Oct 29, 2025 | Michael F Mahoney | Chairman, President & CEO | GRANT | 74.0K | — | — |
| Oct 29, 2025 | Michael F Mahoney | Chairman, President & CEO | GRANT | 88.2K | — | — |
| Oct 28, 2025 | Ellen M Zane | Director | SELL | 2.9K | $102.24 | $297K |
| Oct 27, 2025 | Ellen M Zane | Director | SELL | 10.0K | $101.13 | $1.0M |
| Oct 01, 2025 | Joseph Michael Fitzgerald | EVP & Group Pres, Cardiology | SELL | 8.2K | $98.91 | $815K |
| Oct 01, 2025 | Joseph Michael Fitzgerald | EVP & Group Pres, Cardiology | EXERCISE | 50.0K | $26.15 | $1.3M |
| Oct 01, 2025 | Joseph Michael Fitzgerald | EVP & Group Pres, Cardiology | SELL | 41.8K | $98.38 | $4.1M |
| Sep 02, 2025 | Joseph Michael Fitzgerald | EVP & Group Pres, Cardiology | SELL | 28.2K | $105.85 | $3.0M |
| Sep 02, 2025 | Joseph Michael Fitzgerald | EVP & Group Pres, Cardiology | SELL | 21.8K | $104.89 | $2.3M |
| Sep 02, 2025 | Joseph Michael Fitzgerald | EVP & Group Pres, Cardiology | EXERCISE | 50.0K | $26.15 | $1.3M |